Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H⁺/K⁺-ATPase inhibitors and other xenobiotics

References

• BOWEN, W. P., CAREY, J. E., MIAH, A., MCMURRAY, H. F., MUNDAY, P. W., JAMES, R. S., COLEMAN, R. A. and BROWN, A. M., 2000, Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction. Drug Metabolism and Disposition, 28, 781–788.
   PubMed Web of Science ®Google Scholar
• CHIAROLINI, A., DONATO, M. T., GömEz-LEcHóN, M. J., PALA, M., VALERIO, F. and FERRO, M., 1997, Comparison of rat hepatocyte and differentiated hepatoma cell line cultures as bio-indicators of CYP 1A1 inducers in urban air. Biomarkers, 2, 279–285.
   Google Scholar
• CURI-PEDROSA, R., DAUJAT, M., PICHARD, L., OURLIN, J. C., CLAIR, P., GERVOT, L., LESCA, P., DOMERGUE, J., JoyEux, H. and FOURTANIER, G., 1994, Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. Journal of Pharmacology and Experimental Therapeutics, 269, 384–392.
   Google Scholar
• DAUJAT, M., CHARRASSE, S., FABRE, I., LESCA, P., JOUNAIDI, Y., LARROQUE, C., POELLINGER, L. and MAUREL, P., 1996, Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism. European Journal of Biochemistry, 237, 642–652.
   PubMedGoogle Scholar
• DELESCLUSE, C., LEMAIRE, G., DE SOUSA, G. and RAHMANI, R., 2000, Is CYP1A1 induction always related to AHR signaling pathway? Toxicology, 153, 73–82.
   Google Scholar
• DIAZ, D., FABRE, I., DAUJAT, M., SAINT AUBERT, B., BORIES, P., MICHEL, H. and MAUREL, P., 1990, Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology, 99, 737–747.
   PubMed Web of Science ®Google Scholar
• DOGRA, S. C., WHITELAW, M. L. and MAY, B. K., 1998, Transcriptional activation of cytochrome P450 genes by different classes of chemical inducers. Clinical and Experimental Pharmacology and Physiology, 25, 1–9.
   PubMed Web of Science ®Google Scholar
• FONTAINE, F., DELESCLUSE, C., DE SOUSA, G., LESCA, P. and RAHMANI, R., 1999, Cytochrome 1A1 induction by primaquine in human hepatocytes and HepG2 cells: absence of binding to the aryl hydrocarbon receptor. Biochemical Pharmacology, 57, 255–262.
   PubMed Web of Science ®Google Scholar
• FROTSCHL, R., CHICHMANOV, L., KLEEBERG, U., HILDEBRANDT, A. G., ROOTS, I. and BROCKMOLLER, J., 1998, Prediction of aryl hydrocarbon receptor-mediated enzyme induction of drugs and chemicals by mRNA quantification. Chemical Research in Toxicology, 11, 1447–1452.
   PubMed Web of Science ®Google Scholar
• HAKKOLA, J., PASANEN, M., PELKONEN, o., HUKKANEN, J., EVISALMI, S., ANTTILA, S., RANE, A., MANTYLA, M., PURKUNEN, R., SAARIKOSKI, S., TOOMING, M. and RAUNIO, H., 1997, Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis, 18, 391–397.
   PubMed Web of Science ®Google Scholar
• KLEEBERG, U., FROTSCHL, R., KRUSEKOPF, S., BROCKMOLLER, J., ROOTS, I., RUCKPAUL, K. and HILDEBRANDT, A. G., 1999, Induction of CYP1A by various benzimidazoles and its significance in administrative drug regulation. Drug Metabolism Reviews, 31, 381–392.
   PubMed Web of Science ®Google Scholar
• KRESS, S. and GREENLEE, W. F., 1997, Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Research, 57, 1264–1269.
   PubMed Web of Science ®Google Scholar
• KRUSEKOPF, S., KLEEBERG, U., HILDEBRANDT, A. G. and RUCKPAUL, K., 1997, Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line. Xenobiotica, 27, 1–9.
   PubMed Web of Science ®Google Scholar
• LECLUYSE, E., MADAN, A., HAMILTON, G., CARROLL, K., DEHAAN, R. and PARKINSON, A., 2000, Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. Journal of Biochemical and Molecular Toxicology, 14, 177–188.
   PubMed Web of Science ®Google Scholar
• LEKAS, P., TIN, K. L., LEE, C. and PROKIPCAK, R. D., 2000, The human cytochrome P450 1A1 mRNA is rapidly degraded in HepG2 cells. Archives of Biochemistry and Biophysics, 384, 311–318.
   PubMed Web of Science ®Google Scholar
• Lu, C. and Li, A. P., 2001, Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chemico-Biological Interactions, 134, 271–281.
   PubMed Web of Science ®Google Scholar
• MA, Q. and BALDWIN, K. T., 2002, A cycloheximide-sensitive factor regulates TCDD-induced degradation of the aryl hydrocarbon receptor. Chemosphere, 46, 1491–1500.
   PubMed Web of Science ®Google Scholar
• MA, Q., RENZELLI, A. J., BALDWIN, K. T. and ANTONINI, J. M., 2000, Superinduction of CYP1A1 gene expression. Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of Ah receptor by cycloheximide. Journal of Biological Chemistry, 275, 12676–12683.
   PubMed Web of Science ®Google Scholar
• MASUBUCHI, N., Li, A. P. and OKAZAKI, o., 1998, An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes. Chemico-Biological Interactions, 114, 1–13.
   PubMed Web of Science ®Google Scholar
• POSTLIND, H., Vu, T. P., TUKEY, R. H. and QUATTROCHI, L. C., 1993, Response of human CYP1-luciferase plasmids to 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydro-carbons. Toxicology and Applied Pharmacology, 118, 255–262.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ-ANTONA, C., DONATO, M. T., PAREJA, E., GOMEZ-LECHON, M. J. and CASTELL, J. V., 2001, Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Archives of Biochemistry and Biophysics, 393, 308–315.
   Google Scholar
• ROST, K. L., BROSICKE, H., HEINEMEYER, G. and ROOTS, I., 1994, Specific and dose-dependent enzyme induction by omeprazole in human beings. Hepatology, 20, 1204–1212
   PubMed Web of Science ®Google Scholar
• RUNGE, D., KOHLER, C., KOSTRUBSKY, V. E., JAGER, D., LEHMANN, T., RUNGE, D. M., MAY, U., STOLZ, D. B., STROM, S. C., FLEIG, W. E. and MICHALOPOULOS, G. K., 2000, Induction of cytochrome P450, CYP1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance, MDR-1, and multidrug resistance associated protein, MRP-1, by prototypical inducers in human hepatocytes. Biochemical and Biophysical Research Communications, 273, 333–341.
   PubMed Web of Science ®Google Scholar
• SHEHIN, S. E., STEPHENSON, R. o. and GREENLEE, W. F., 2000, Transcriptional regulation of the human CYP1B1 gene. Evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression. Journal of Biological Chemistry, 275, 6770–6776.
   PubMed Web of Science ®Google Scholar
• SHIH, H., PICKWELL, G. V., GUENETTE, D. K., BILIR, B. and QUATTROCHI, L. C., 1999, Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole. Human and Experimental Toxicology, 18, 95–105.
   PubMed Web of Science ®Google Scholar
• SPINK, D. C., HAYES, C. L., YOUNG, N. R., CHRISTOU, M., SUTTER, T. R., JEFCOATE, C. R. and GIERTHY, J. F., 1994, The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 beta-estradiol 4-hydroxylase. Journal of Steroid Biochemistry and Molecular Biology, 51, 251–258.
   PubMed Web of Science ®Google Scholar
• WERLINDER, V., BACKLUND, M., ZHUKOV, A. and INGELMAN-SUNDBERG, M., 2001, Transcriptional and post-translational regulation of CYP1A1 by primaquine. Journal of Pharmacology and Experimental Therapeutics, 297, 206–214.
   Google Scholar